United States Biotechnology & Medical Research

Krystal Biotech Inc (KRYS)

Track

Over the past 90 days, Krystal Biotech Inc. insiders have executed 28 transactions, resulting in a net sell value of approximately $15.2 million. Key executives, including the CEO and President of R&D, have consistently sold shares following the company's recent earnings report. The stock has appreciated 38.8% during this period, trading near its 52-week high.
Ticker: KRYS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Krystal Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Thomas John Charles
EVP, General Counsel
2 sales — total 200,000 USD
Planned sale 25 Jun 2026
Value US$3,723,254.60 | Price 218.09 | Shares 21,658
Proposed sale 25 Jun 2026
Value US$4,271,128.12 | Price 50.85 | Shares 13,695
Sale 4 Jun 2026
Value US$2,386,274.65 | Price 442.32 | Shares 33,132
Sale 4 Jun 2026
Value US$1,088,492.55 | Price 459.88 | Shares 26,357
Sale 4 Jun 2026
Value US$823,257.71 | Price 310.43 | Shares 2,652
Sale 4 Jun 2026
Value US$861,620.44 | Price 309.49 | Shares 2,784
Sale 4 Jun 2026
Value US$1,489,898.99 | Price 308.47 | Shares 4,830
Sale 4 Jun 2026
Value US$3,526,292.97 | Price 307.68 | Shares 11,461
Sale 4 Jun 2026
Value US$180,429.43 | Price 306.33 | Shares 589
Sale 4 Jun 2026
Value US$165,816.75 | Price 304.81 | Shares 544
Sale 4 Jun 2026
Value US$53,357.73 | Price 303.17 | Shares 176
Sale 4 Jun 2026
Value US$193,431.49 | Price 302.24 | Shares 640
Planned sale 4 Jun 2026
Value US$96,240.00 | Price 300.75 | Shares 320
Sale 4 Jun 2026
Value US$74,796.00 | Price 311.65 | Shares 240
Sale 4 Jun 2026
Value US$634,000.54 | Price 310.94 | Shares 2,039
Sale 4 Jun 2026
Value US$868,156.23 | Price 309.95 | Shares 2,801
Sale 4 Jun 2026
Value US$1,174,707.91 | Price 308.89 | Shares 3,803
Sale 4 Jun 2026
Value US$3,918,070.21 | Price 307.81 | Shares 12,729
Sale 4 Jun 2026
Value US$413,963.79 | Price 307.09 | Shares 1,348
Sale 4 Jun 2026
Value US$146,815.20 | Price 305.87 | Shares 480
Sale 4 Jun 2026
Value US$121,957.56 | Price 304.89 | Shares 400
Sale 4 Jun 2026
Value US$74,883.06 | Price 303.17 | Shares 247
Sale 4 Jun 2026
Value US$179,234.72 | Price 302.25 | Shares 593
Planned sale 4 Jun 2026
Value US$96,240.00 | Price 300.75 | Shares 320
Proposed sale 4 Jun 2026
Value US$7,545,500.00 | Price 301.82 | Shares 25,000
Proposed sale 4 Jun 2026
Value US$7,545,500.00 | Price 301.82 | Shares 25,000
Planned sale 26 May 2026
Value US$193,903.26 | Price 302.03 | Shares 642
Proposed sale 26 May 2026
Value US$193,903.26 | Price 302.03 | Shares 642
Sale 4 Mar 2026
Value US$452,918.08 | Price 266.42 | Shares 1,700
Sale 4 Mar 2026
Value US$1,590,979.20 | Price 265.16 | Shares 6,000
Sale 4 Mar 2026
Value US$1,284,019.21 | Price 264.64 | Shares 4,852
Sale 4 Mar 2026
Value US$592,534.81 | Price 263.58 | Shares 2,248
Sale 4 Mar 2026
Value US$508,430.23 | Price 262.35 | Shares 1,938
Sale 4 Mar 2026
Value US$766,198.28 | Price 261.41 | Shares 2,931
Sale 4 Mar 2026
Value US$954,762.49 | Price 260.37 | Shares 3,667
Sale 4 Mar 2026
Value US$173,419.15 | Price 259.61 | Shares 668
Sale 4 Mar 2026
Value US$152,280.30 | Price 258.54 | Shares 589
Planned sale 4 Mar 2026
Value US$104,728.67 | Price 257.32 | Shares 407
Sale 4 Mar 2026
Value US$245,230.60 | Price 266.56 | Shares 920
Sale 4 Mar 2026
Value US$647,773.03 | Price 265.59 | Shares 2,439
Sale 4 Mar 2026
Value US$2,330,151.18 | Price 264.85 | Shares 8,798
Sale 4 Mar 2026
Value US$538,741.35 | Price 263.70 | Shares 2,043
Sale 4 Mar 2026
Value US$624,618.62 | Price 262.44 | Shares 2,380
Sale 4 Mar 2026
Value US$774,289.02 | Price 261.41 | Shares 2,962
Sale 4 Mar 2026
Value US$814,802.40 | Price 260.49 | Shares 3,128
Sale 4 Mar 2026
Value US$357,837.55 | Price 259.87 | Shares 1,377
Sale 4 Mar 2026
Value US$121,438.36 | Price 258.38 | Shares 470
Planned sale 4 Mar 2026
Value US$124,282.23 | Price 257.31 | Shares 483
Proposed sale 4 Mar 2026
Value US$6,595,000.00 | Price 263.80 | Shares 25,000
Proposed sale 4 Mar 2026
Value US$6,595,000.00 | Price 263.80 | Shares 25,000
Planned sale 2 Mar 2026
Value US$200,700.00 | Price 267.60 | Shares 750
Proposed sale 2 Mar 2026
Value US$200,700.00 | Price 267.60 | Shares 750
Planned sale 27 Feb 2026
Value US$655,343.10 | Price 276.17 | Shares 2,373
Planned sale 27 Feb 2026
Value US$2,597,481.24 | Price 275.45 | Shares 9,430
Proposed sale 27 Feb 2026
Value US$3,252,823.82 | Price 275.59 | Shares 11,803
Planned sale 26 Feb 2026
Value US$728,919.50 | Price 276.32 | Shares 2,638
Planned sale 26 Feb 2026
Value US$1,404,759.96 | Price 275.28 | Shares 5,103
Proposed sale 26 Feb 2026
Value US$2,133,679.50 | Price 275.63 | Shares 7,741
Planned sale 25 Feb 2026
Value US$192,500.00 | Price 275.00 | Shares 700
Proposed sale 25 Feb 2026
Value US$192,500.00 | Price 275.00 | Shares 700
Planned sale 24 Feb 2026
Value US$666,626.92 | Price 274.90 | Shares 2,425
Planned sale 24 Feb 2026
Value US$250,636.21 | Price 269.50 | Shares 930
Planned sale 24 Feb 2026
Value US$449,746.88 | Price 268.67 | Shares 1,674
Planned sale 24 Feb 2026
Value US$505,596.67 | Price 267.37 | Shares 1,891
Planned sale 24 Feb 2026
Value US$1,156,878.93 | Price 266.62 | Shares 4,339
Planned sale 24 Feb 2026
Value US$425,919.10 | Price 265.54 | Shares 1,604
Planned sale 24 Feb 2026
Value US$238,136.04 | Price 264.60 | Shares 900
Planned sale 24 Feb 2026
Value US$16,309.17 | Price 263.05 | Shares 62
Sale 24 Feb 2026
Value US$101,117.99 | Price 271.09 | Shares 373
Sale 24 Feb 2026
Value US$99,836.43 | Price 269.83 | Shares 370
Sale 24 Feb 2026
Value US$1,065,923.75 | Price 268.97 | Shares 3,963
Sale 24 Feb 2026
Value US$1,788,079.50 | Price 268.04 | Shares 6,671
Sale 24 Feb 2026
Value US$3,116,310.46 | Price 266.97 | Shares 11,673
Sale 24 Feb 2026
Value US$2,391,885.39 | Price 266.18 | Shares 8,986
Sale 24 Feb 2026
Value US$942,878.18 | Price 265.08 | Shares 3,557
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-25 PlS Planned sale
Thomas John Charles

EVP, General Counsel

Officer
21,658 +5.1%
218.09
US$3,723,255 		21,658 +5.1% 218.09 US$3,723,255
2026-06-25 2026-06-25 PrS Proposed sale
Thomas John Charles

Officer

Officer
13,695
50.85
US$4,271,128 		13,695 50.85 US$4,271,128
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
33,132 +10.0%
442.32
US$2,386,275 		33,132 +10.0% 442.32 US$2,386,275
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
964 -0.1%
311.36
US$300,149 		964 -0.1% 311.36 US$300,149
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,652 -0.2%
310.43
US$823,258 		2,652 -0.2% 310.43 US$823,258
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,784 -0.2%
309.49
US$861,620 		2,784 -0.2% 309.49 US$861,620
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
4,830 -0.3%
308.47
US$1,489,899 		4,830 -0.3% 308.47 US$1,489,899
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
11,461 -0.8%
307.68
US$3,526,293 		11,461 -0.8% 307.68 US$3,526,293
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
589 -0.0%
306.33
US$180,429 		589 -0.0% 306.33 US$180,429
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
544 -0.0%
304.81
US$165,817 		544 -0.0% 304.81 US$165,817
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
176 -0.0%
303.17
US$53,358 		176 -0.0% 303.17 US$53,358
2026-06-05 2026-06-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
640 -0.0%
302.24
US$193,431 		640 -0.0% 302.24 US$193,431
2026-06-05 2026-06-04 PlS Planned sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
320 -0.0%
300.75
US$96,240 		320 -0.0% 300.75 US$96,240
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
240 -0.0%
311.65
US$74,796 		240 -0.0% 311.65 US$74,796
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
2,039 -0.1%
310.94
US$634,001 		2,039 -0.1% 310.94 US$634,001
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
2,801 -0.2%
309.95
US$868,156 		2,801 -0.2% 309.95 US$868,156
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
3,803 -0.3%
308.89
US$1,174,708 		3,803 -0.3% 308.89 US$1,174,708
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
12,729 -0.9%
307.81
US$3,918,070 		12,729 -0.9% 307.81 US$3,918,070
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
1,348 -0.1%
307.09
US$413,964 		1,348 -0.1% 307.09 US$413,964
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
480 -0.0%
305.87
US$146,815 		480 -0.0% 305.87 US$146,815
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
400 -0.0%
304.89
US$121,958 		400 -0.0% 304.89 US$121,958
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
247 -0.0%
303.17
US$74,883 		247 -0.0% 303.17 US$74,883
2026-06-05 2026-06-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
593 -0.0%
302.25
US$179,235 		593 -0.0% 302.25 US$179,235
2026-06-05 2026-06-04 PlS Planned sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
320 -0.0%
300.75
US$96,240 		320 -0.0% 300.75 US$96,240
2026-06-04 2026-06-04 PrS Proposed sale
2.4
KRISH KRISHNAN

Director; Officer; 10% Stockholder

Executive Director Large shareholder
25,000
301.82
US$7,545,500 		25,000 301.82 US$7,545,500
2026-06-04 2026-06-04 PrS Proposed sale
2.2
SUMA KRISHNAN

Director; Officer; 10% Stockholder

Executive Director Large shareholder
25,000
301.82
US$7,545,500 		25,000 301.82 US$7,545,500
2026-05-27 2026-05-26 PlS Planned sale
Thomas John Charles

EVP, General Counsel

Officer
642 -100.0%
302.03
US$193,903 		642 -100.0% 302.03 US$193,903
2026-05-26 2026-05-26 PrS Proposed sale
Thomas John Charles

Officer

Officer
642
302.03
US$193,903 		642 302.03 US$193,903
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
1,700 -0.1%
266.42
US$452,918 		1,700 -0.1% 266.42 US$452,918
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
6,000 -0.4%
265.16
US$1,590,979 		6,000 -0.4% 265.16 US$1,590,979
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
4,852 -0.3%
264.64
US$1,284,019 		4,852 -0.3% 264.64 US$1,284,019
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
2,248 -0.2%
263.58
US$592,535 		2,248 -0.2% 263.58 US$592,535
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
1,938 -0.1%
262.35
US$508,430 		1,938 -0.1% 262.35 US$508,430
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
2,931 -0.2%
261.41
US$766,198 		2,931 -0.2% 261.41 US$766,198
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
3,667 -0.3%
260.37
US$954,762 		3,667 -0.3% 260.37 US$954,762
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
668 -0.0%
259.61
US$173,419 		668 -0.0% 259.61 US$173,419
2026-03-06 2026-03-04 S Sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
589 -0.0%
258.54
US$152,280 		589 -0.0% 258.54 US$152,280
2026-03-06 2026-03-04 PlS Planned sale
2.2
Krishnan Suma

President, R&D

Executive Director Large shareholder
407 -0.0%
257.32
US$104,729 		407 -0.0% 257.32 US$104,729
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
920 -0.1%
266.56
US$245,231 		920 -0.1% 266.56 US$245,231
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,439 -0.2%
265.59
US$647,773 		2,439 -0.2% 265.59 US$647,773
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
8,798 -0.6%
264.85
US$2,330,151 		8,798 -0.6% 264.85 US$2,330,151
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,043 -0.1%
263.70
US$538,741 		2,043 -0.1% 263.70 US$538,741
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,380 -0.2%
262.44
US$624,619 		2,380 -0.2% 262.44 US$624,619
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
2,962 -0.2%
261.41
US$774,289 		2,962 -0.2% 261.41 US$774,289
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
3,128 -0.2%
260.49
US$814,802 		3,128 -0.2% 260.49 US$814,802
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
1,377 -0.1%
259.87
US$357,838 		1,377 -0.1% 259.87 US$357,838
2026-03-06 2026-03-04 S Sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
470 -0.0%
258.38
US$121,438 		470 -0.0% 258.38 US$121,438
2026-03-06 2026-03-04 PlS Planned sale
2.4
Krishnan Krish S

President and CEO

Executive Director Large shareholder
483 -0.0%
257.31
US$124,282 		483 -0.0% 257.31 US$124,282
2026-03-04 2026-03-04 PrS Proposed sale
2.2
SUMA KRISHNAN

Director; Officer; 10% Stockholder

Executive Director Large shareholder
25,000
263.80
US$6,595,000 		25,000 263.80 US$6,595,000
2026-03-04 2026-03-04 PrS Proposed sale
2.4
KRISH KRISHNAN

Director; Officer; 10% Stockholder

Executive Director Large shareholder
25,000
263.80
US$6,595,000 		25,000 263.80 US$6,595,000
2026-03-03 2026-03-02 PlS Planned sale
1.5
ROMANO KATHRYN

Chief Accounting Officer

Officer
750 -3.2%
267.60
US$200,700 		750 -3.2% 267.60 US$200,700
2026-03-02 2026-03-02 PrS Proposed sale
1.5
ROMANO KATHRYN

Officer

Officer
750
267.60
US$200,700 		750 267.60 US$200,700
2026-03-03 2026-02-27 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
2,373 -3.1%
276.17
US$655,343 		2,373 -3.1% 276.17 US$655,343
2026-03-03 2026-02-27 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
9,430 -11.1%
275.45
US$2,597,481 		9,430 -11.1% 275.45 US$2,597,481
2026-02-27 2026-02-27 PrS Proposed sale
3.4
Daniel S Janney

Director

Non-Executive Director
11,803
275.59
US$3,252,824 		11,803 275.59 US$3,252,824
2026-02-26 2026-02-26 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
2,638 -3.0%
276.32
US$728,919 		2,638 -3.0% 276.32 US$728,919
2026-02-26 2026-02-26 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
5,103 -5.5%
275.28
US$1,404,760 		5,103 -5.5% 275.28 US$1,404,760
2026-02-26 2026-02-26 PrS Proposed sale
3.4
Daniel S Janney

Director

Non-Executive Director
7,741
275.63
US$2,133,680 		7,741 275.63 US$2,133,680
2026-02-26 2026-02-25 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
700 -0.7%
275.00
US$192,500 		700 -0.7% 275.00 US$192,500
2026-02-25 2026-02-25 PrS Proposed sale
3.4
Daniel S Janney

Director

Non-Executive Director
700
275.00
US$192,500 		700 275.00 US$192,500
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
2,425 -2.5%
274.90
US$666,627 		2,425 -2.5% 274.90 US$666,627
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
930 -1.0%
269.50
US$250,636 		930 -1.0% 269.50 US$250,636
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
1,674 -1.7%
268.67
US$449,747 		1,674 -1.7% 268.67 US$449,747
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
1,891 -1.9%
267.37
US$505,597 		1,891 -1.9% 267.37 US$505,597
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
4,339 -4.1%
266.62
US$1,156,879 		4,339 -4.1% 266.62 US$1,156,879
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
1,604 -1.5%
265.54
US$425,919 		1,604 -1.5% 265.54 US$425,919
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
900 -0.8%
264.60
US$238,136 		900 -0.8% 264.60 US$238,136
2026-02-26 2026-02-24 PlS Planned sale
3.4
JANNEY DANIEL
Non-Executive Director
62 -0.1%
263.05
US$16,309 		62 -0.1% 263.05 US$16,309
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
373 -100.0%
271.09
US$101,118 		373 -100.0% 271.09 US$101,118
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
370 -49.8%
269.83
US$99,836 		370 -49.8% 269.83 US$99,836
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
3,963 -84.2%
268.97
US$1,065,924 		3,963 -84.2% 268.97 US$1,065,924
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
6,671 -58.6%
268.04
US$1,788,079 		6,671 -58.6% 268.04 US$1,788,079
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
11,673 -50.6%
266.97
US$3,116,310 		11,673 -50.6% 266.97 US$3,116,310
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
8,986 -28.0%
266.18
US$2,391,885 		8,986 -28.0% 266.18 US$2,391,885
2026-02-26 2026-02-24 S Sale
3.4
JANNEY DANIEL
Non-Executive Director
3,557 -10.0%
265.08
US$942,878 		3,557 -10.0% 265.08 US$942,878
Explore more

More insider trading research around Krystal Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America